Trulieve Cannabis (TRLV) EBIT Margin (2020 - 2026)

Trulieve Cannabis has reported EBIT Margin for 7 years, with the latest figure at 136.75% in Q2 2026.

• On a quarterly basis, EBIT Margin fell 15417.0% year-over-year to 136.75% in Q2 2026; TTM through Jun 2026 was 24.34%, a 3176.0% decrease from a year earlier, with the FY2025 full-year figure at 12.15%, up 391.0% from the prior year.
• EBIT Margin was 136.75% for Q2 2026 at Trulieve Cannabis, down from 12.46% in the prior quarter.
• The five-year high for EBIT Margin was 17.42% in Q2 2025, with the low at 136.75% in Q2 2026.
• Average EBIT Margin over 5 years is 5.95%, with a median of 8.83% recorded in 2022.
• The sharpest annual moves came in 2024 and 2026: EBIT Margin surged 11977 bps in 2024, then plunged 15417 bps in 2026.
• Over 5 years, EBIT Margin stood at 1.74% in 2022, then surged by 483 bps to 10.17% in 2023, then sank by 96 bps to 0.43% in 2024, then soared by 1101 bps to 5.22% in 2025, then slumped by 2721 bps to 136.75% in 2026.
• The last three EBIT Margin figures came in at 136.75% (Q2 2026), 12.46% (Q1 2026), and 5.22% (Q4 2025), per Business Quant data.